Sun Pharmaceutical Industries Limited (SUNPHARMA) Share Price & AI Investment Analysis

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets. Track Sun Pharmaceutical Industries Limited's live NSE:SUNPHARMA share price ₹1,866.80 (+0.10%), market cap ₹₹4.48T, P/E 37.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SUNPHARMA — real-time NSE India stock intelligence.